A narrative literature review on the clinical utility of activated partial thromboplastin time and anti-factor Xa activity assays in cancer patients with anticoagulant therapy
A synergistic approach combining both assays, tailored to the specific anticoagulant, patient factors, and clinical context, appears optimal for evidence-based, individualized anticoagulation management in cancer patients. Future large-scale trials are needed to validate correlations between monitoring results and clinical endpoints.
Authors
- Jie Zhao (ORCID: https://orcid.org/0000-0003-1168-8384)
- Yanhong Chen (ORCID: https://orcid.org/0000-0002-9550-6906)
- Xiaofang Zhang (ORCID: https://orcid.org/0000-0001-7184-1526)
- Lihong Song (ORCID: https://orcid.org/0000-0001-6783-1050)
- Haixin Li (ORCID: https://orcid.org/0000-0002-9200-7642)
Institutions
- Handan College (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2025-10-01
- DOI
- https://doi.org/10.21037/tcr-2025-1944
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00